178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Increased use of partial knee replacement could save the NHS £30 million per year

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th

Increased use of partial knee replacement could save the NHS £30 million per year

by University of OxfordCredit: NDORMSNew research from a randomised clinical trial published today inThe Lancetand funded by the National Institute for Health Research (NIHR) shows th
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe
Inactivity and obesity relate to cognitive impairment in lupus

Inactivity and obesity relate to cognitive impairment in lupus

(HealthDay) -- Physical inactivity and obesity are associated with impaired cognitive function, especially executive functions, in women with systemic lupus erythematosus (SLE), according to research

Inactivity and obesity relate to cognitive impairment in lupus

(HealthDay) -- Physical inactivity and obesity are associated with impaired cognitive function, especially executive functions, in women with systemic lupus erythematosus (SLE), according to research
Can gut bacteria cause rheumatoid arthritis?

Can gut bacteria cause rheumatoid arthritis?

by Greg Glasgow,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers at the University of Colorado School of Medicine have discovered that a unique bacteria found in the gut co

Can gut bacteria cause rheumatoid arthritis?

by Greg Glasgow,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainResearchers at the University of Colorado School of Medicine have discovered that a unique bacteria found in the gut co
Role of ECHO emphasized in management of rheumatic heart disease

Role of ECHO emphasized in management of rheumatic heart disease

by Elana GotkineIn a report from the American Society of Echocardiography, published in the Jan. 1 issue of theJournal of the American Society of Echocardiography, the authors emphasize the role

Role of ECHO emphasized in management of rheumatic heart disease

by Elana GotkineIn a report from the American Society of Echocardiography, published in the Jan. 1 issue of theJournal of the American Society of Echocardiography, the authors emphasize the role
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
How B cells recognize new variants of SARS-CoV-2

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of
Prevalence of knee OA lower with menopausal hormone therapy

Prevalence of knee OA lower with menopausal hormone therapy

(HealthDay)—For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 inMenopause.Jae Hyun

Prevalence of knee OA lower with menopausal hormone therapy

(HealthDay)—For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 inMenopause.Jae Hyun
Smokers with rheumatoid arthritis face extra barriers to quitting

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota
Rheumatism drug also effective at half dose

Rheumatism drug also effective at half dose

by Medical University of ViennaThe treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of

Rheumatism drug also effective at half dose

by Medical University of ViennaThe treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of
Study: Why people with knee osteoarthritis experience different kinds of pain

Study: Why people with knee osteoarthritis experience different kinds of pain

by Boston University School of MedicineCredit: CC0 Public DomainOsteoarthritis is the most common form of arthritis worldwide, affecting more than 300 million people. It causes substantial pain,

Study: Why people with knee osteoarthritis experience different kinds of pain

by Boston University School of MedicineCredit: CC0 Public DomainOsteoarthritis is the most common form of arthritis worldwide, affecting more than 300 million people. It causes substantial pain,